US Patent 11497734 Dual inhibitors of TIM-3 and PD-1 pathways
Patent 11497734 was granted and assigned to Aurigene Discovery Technologies on November, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11497734 Dual inhibitors of TIM-3 and PD-1 pathways
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.